A RARE AND INTERESTING CASE REPORT OF OVARIAN STEROID CELL TUMOR
Abstract
Sex cord-stromal tumors account for 5
percent of all ovarian tumors and 2 percent
of malignant ovarian tumors. Steroid
cell tumors (SCT), not otherwise specified
(NOS), are rare sex cord-stromal tumors
of the ovary and account for less
than 0.1 percent of all ovarian tumors.
The functional designation steroid cell
tumors was suggested and classified into
3 subclasses as Stromal luteoma, leydig
cell tumor and steroid cell tumors (Not
otherwise specified). We report a rare
case of a post-menopausal woman presented
with virilism.
Full Text:
PDFReferences
R.H. Young, P.B. Clement, and R.E.
scully, “Sex-cord stromal, steroid cell
and germ all tumors of the ovary”, in
sternberg’s Diagnostic surgical pathology,
S.E. Mills, D.Carter, J.K. Greenson,
H.A. Oberman, V. Reuter and M.H.
Stoler, Eds, PP. 2579-2615, Lippincott
Williams and Wilkins, Philadelphia, USA,
th edition 2004.
Taylor HB, Norris HJ: Lipid cell tumors
of the ovary cancer 20: 1953-
, 1967.
Hayes MC, Scully RE, Ovarian steroid
cell tumors (Not otherwise specified). A
clinicopathological analysis of 63 cases
In J Surg Pathol 1987; 835-45.
R.E. Scully “Tumors of the ovary
and maldeveloped gonads” in Has
of tumor pathology, 2nd series, fascicle
No. 16, Armed forces Institute of
Pathology, Washington, De, USA,
; 239-312.
R.H. Young, and R.E. Scully, “Sex
cord stromal, steroid cell and
other ovarian tumors with endocrine,
paraendocrine and Paraneoplastic
manifestation” in Blausteins
pathology of female genital tract, R.J.
Kumaran, Ed, PP 783-847, Springer,
new York, NY, USA, 4th Edition,
Brewer CA, Shevlin D. Encouraging
response of an advance steroid
cell tumor to GnRH agonist therapy.
Obstetric – Gynecology 1998,
(4 pt 2): 661 – 3.
Wang PH, Chao HT, Lee WL. Use
of a long-acting gonadotropin – releasing
hormone agonist for treatment
of steroid cell tumors of the
ovary, Fertil steril 1998; 69; 353-5
Young RH, Scully RE, Steroid cell
tumors of the ovary. Obstetric and
Gynaecological pathology, Edited by
Fox H, Wells M Spain, Churchill Livingstone,
; 845-46.
Parker CR Jr, Servy E, Mc
Donough PG et al: In vivo endocrine
studies in adrenal test tumor of the
ovary. Obstetric - Gynecology 44:
, 1974.
Rosner JM, Conte NF, Horita S,
et al: In vivo and in vitro production
of testosterone by a lipid ovarian
tumor Am J Med 37: 638 – 642,
Lipsett MD Kirscner MA, Wilson H
et al: Malignant lipid cell tumor of
the ovary: Clinical, biochemical, and
etiological considerations. J Clin Endocrinol
: 336-344 1970.
Bonaventura LM, Judd H, Roth
LM et al: Androgen, estrogen, and
progesterone production by a lipid cell
tumor of the ovary. AM J Obstet Gynecol
; 403-409, 1978.
Hughie dons PE, Ovarian Lipoid
& thecal cell tumors. Their origins
and inter relationships. Obstet Gynecol
Surv 21: 245-288, 1966.
Powel JL, Dulaney DP, Shiro BC.
Androgen secreting steroid cell tumor
of the ovary, South Med J 2000;
(12): 1201-04.
Outwater EK, WAGNER BJ, MANNION
E, Mc Larkey JK, et al. Sex cord
– stromal and steroid cell tumors of
ovary. Radiographics 1998; 18: 1523
– 46
Haji AG, Sharma S, Basu M, Vijay
Kumar DK, et al. Androgen secreting
steroid cell tumor ofthe ovary in a
young lactating woman with acute onset
severe hyperandrogenism : A case
report andreview of literature. Journal
of medical Care Reports 2007; (1):
`17 Benign and malignant ovarian steroid
cell tumors, not otherwise specified:
case studies, comparison, and
review of the literature Wei Jiang,
Xiang Tao, Fang Fang, Shaofen
Zhang and Congjian Xu, Jiang et al.
Journal of Ovarian Research 2013,
:53
Steroid cell tumor not otherwise
specified of bilateral ovaries: A rare
cause of post menopausal virilization;
Samanthi M A Cooray et al, Indian J
Endocrinology and Metabolism 2013;
-7; 262-264
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An initiative of The Tamil Nadu Dr M.G.R. Medical University